FindTrial
Sign In

Impact of Hematopoietic Stem Cell Transplantation Conditioning Treatment on Gonadal Function in Children and Adolescent

Impact of Hematopoietic Stem Cell Transplantation Conditioning Treatment on Gonadal Function in Children and Adolescent

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128262
Enrollment
Unknown
Registered
2026-07-16
Start date
2026-07-16
Completion date
Unknown
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases that require hematopoietic stem cell transplantation

Interventions

chemical/radiotherapy condition treatment groups:None
CAR-T treatment groups:None

Sponsors

West China The Second Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 3-18 who undergo hematopoietic stem cell transplantation for the first time; 2. Use chemical/radiotherapy condition treatment and CAR-T treatment before transplantation

Exclusion criteria

Exclusion criteria: 1. There are congenital diseases related to the function of the gonads 2. There are other related diseases that cause gonadal dysfunction ( primary/ secondary) 3. Death within 1 year after transplantation

Design outcomes

Primary

MeasureTime frame
Basic level of sex hormones;Gynecological uterine/appendage color ultrasound examination;Testicular color ultrasound examination;—

Countries

China

Contacts

Public ContactLinan Zeng

West China The Second Hospital

linanzeng@scu.edu.cn+86 198 2896 6030

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026